SARS-CoV-2 Serologic Surveillance Among People Living with HIV in Nigeria, April 2022-January 2023.

Autor: Chun HM; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Electronic address: vgi2@cdc.gov., Osawe S; Institute of Human Virology, Abuja, FCT, Nigeria., Adams-Dabban S; Institute of Human Virology, Abuja, FCT, Nigeria., Favaloro J; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Iriemenam NC; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Dirlikov E; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention Mozambique, Maputo, Mozambique., Martin D; Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia., Milligan K; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Peraton Inc., Herndon, VA, USA., Abutu A; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Okunoye O; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Okoli M; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Akanbi O; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Akinmulero O; Institute of Human Virology, Abuja, FCT, Nigeria., Okonkwo R; Institute of Human Virology, Abuja, FCT, Nigeria., Oyedele O; Institute of Human Virology, Abuja, FCT, Nigeria., Greby S; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Abimiku A; Institute of Human Virology, Abuja, FCT, Nigeria., Okoye MIJ; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Shiraishi RW; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Adegoke D; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Bello M; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Villeng F; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Item II; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Gabo S; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Abubakar A; Institute of Human Virology, Abuja, FCT, Nigeria., Thomas A; Institute of Human Virology, Abuja, FCT, Nigeria., Olaleye T; Institute of Human Virology, Abuja, FCT, Nigeria., Awala S; Institute of Human Virology, Abuja, FCT, Nigeria., Nwatu F; Institute of Human Virology, Abuja, FCT, Nigeria., Ugboaja B; Institute of Human Virology, Abuja, FCT, Nigeria., Udoh I; Institute of Human Virology, Abuja, FCT, Nigeria., Akayi L; Institute of Human Virology, Abuja, FCT, Nigeria., Dattijo J; Institute of Human Virology, Abuja, FCT, Nigeria., Adenekan T; Institute of Human Virology, Abuja, FCT, Nigeria., Aminu-Alhaji A; Division of Global Health Protection, US Centers for Disease Control and Prevention Abuja, FCT, Nigeria., Ezeuko I; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Nov 21, pp. 107309. Date of Electronic Publication: 2024 Nov 21.